期刊文献+

姜黄素对阿尔采末病中APP淀粉样酶切途径的调控作用 被引量:14

The regulation of Curcumin on the amyloidogentic pathaway of APP in Alzheimer's disease
暂未订购
导出
摘要 目的研究姜黄素作用于阿尔采末病中APP淀粉样酶切途径的环节,探讨其抑制Aβ产生的作用机制。方法体外培养SHSY5Y细胞,以LipofectaminTM2000脂质体介导瞬时共转染pBACE1-mychis和pAPPswe两种质粒,姜黄素(0、1.25、5.0、20μmol.L-1)处理转染后的SHSY5Y细胞24h,以及5μmol.L-1姜黄素按时间梯度(0、12、24、48h)分别处理转染后的SHSY5Y细胞,通过RT-PCR检测APP和BACE1mRNA水平,Western blot检测BACE1和C99蛋白表达情况,ELISA检测Aβ40/42水平。结果经姜黄素处理后APP和BACE1mRNA表达水平都有明显减弱,呈浓度-时间依赖性(P<0.05);BACE1和C99蛋白表达也有不同程度的下调,呈浓度-时间依赖性(P<0.05);Aβ40/42表达水平明显降低,呈浓度-时间依赖性(P<0.05)。结论姜黄素能够抑制阿尔采末病相关基因APP mRNA表达;抑制APP的限速酶BACE1mRNA和蛋白表达;并抑制APP分解产物C99蛋白表达,都呈浓度-时间依赖性(P<0.05)。此外,姜黄素可以明显抑制APP的分解产物Aβ40/42的产生。 Aim To investigate the effects of Curcumin on the APP processing in the amyloidogenie pathway in vitro and explore its mechanisms on Aβ generation inhibition. Methods Plasmids APPswe and BACE1-mychis were transiently co-transfected in SH-SY5Y cell by Lipofectamin^TM 2000. The cell line then treated with Curcumin at 0, 1.25, 5, 20 umol·L^-1 for 24 h, or with Curcumin at 5 umol·L^-1 for0, 12, 24 and48 h for the time course assay. RT-PCR were performed to measure the endogenous levels of APP and BACE1 mRNA. Western blot were used to detect the protein expression of BACE1 and C99, the major β-secretase cleavage product. The concentration of AI540/42 was detected by β-amyloid 1 -40 or 42 Colorimetric ELISA. Results RT-PCR results showed that the mRNA levels of APP and BACE1 were decreased obviously in a dose-and time-dependent manner after treated with Cureumin in SH-SY5Y (P 〈 0. 05). Western Blotting results showed that the expression of BACE1 and C99 protein were all decreased in a dose-and time-dependent manner (P 〈 0.05). ELISA results showed that the generation of Aβ40/42 reduced significantly, also in a dose-and time-dependent manner (P 〈 0.05 ). Conclusion Our finding demonstrated that Curcumin could inhibit the expression of the APP at mRNA; the expression of the BACE1 at mRNA and protein levels, furthermore it could inhibit the generation of Aβ40/42, and those changes were dose-time dependent (P 〈0. 05). Those factors are key components in APP amyloidogenie pathway.
出处 《中国药理学通报》 CAS CSCD 北大核心 2009年第3期361-366,共6页 Chinese Pharmacological Bulletin
基金 国家自然科学基金资助项目(No30600196) 重庆市自然科学基金资助项目(NoCSTC 2006BB5042) 2007年教育部留学回国人员科研启动基金(No教外司留[2007]1108号)
关键词 阿尔采末病 姜黄素 APP BACE1 Alzheimer's disease curcumin APP BACE1
  • 相关文献

参考文献14

  • 1杨金环,黄河胜,查向东,陈青峰.阿尔采末病的发病机制、早期诊断及治疗的新策略[J].中国药理学通报,2007,23(7):847-850. 被引量:4
  • 2Shishir S H, Gautam S E, Bharath A G, et al. Curcumin : getting back to the roots [ J ]. Ann N Y Acad Sci, 2005, 1056:206 - 17.
  • 3Ono K, Naiki H, Yamada M, et al. The devolepment of preventives and therapeutics for Alzheimer's disease that inhibite the formation of beta-amyloid fibrils( fAbeta), as well as destabize preformed fAbta[ J]. Curt Pham Des, 2006, 12(33) :4357 -75.
  • 4Zhang Y W, Xu H. Molecular and cellular mechanisms for alzheimer's disease : understanding APP metabolism[ J]. Curr Mol Med, 2007,7(7) : 687 -96.
  • 5Cai H, Wang Y, McCarthy D, et al. BACE1 is the major beta - secretase for generation of A beta peptides by neurons [ J ]. Nat Neurosci, 2001,4(3) : 233 -4.
  • 6Hook V Y, Reisine T D. Cysteine proteases are the major β-secretase in the regulated secretory pathway that provides most of the β- amyloid in Alzheimer's disease:role of BACE1 in the constitutive secretory pathway [ J ]. Neurosci Res,2003, 74 ( 3 ) : 393 - 405.
  • 7Haray J A, Higgins G A. Alzheimer's disease: the amyloid cascade hypothesis[ J]. Science, 1992, 256 : 184 -5.
  • 8Hardy J, Selkoe D J. The amyloid hypothesis of Alzheimer's disease:progress and problems on the road to therapeutics. Science, 2002,297(5580) :353 -6.
  • 9王月华,杜冠华.治疗阿尔采末病的药物靶点:β-分泌酶[J].中国药理学通报,2003,19(6):609-613. 被引量:3
  • 10Aggarwal B B, Sundaram C, Malani N, et al. Curcumin: the Indian solid gold[ J]. Adv Exp Med Biol, 2007, 595 : 1 - 75.

二级参考文献5

共引文献5

同被引文献110

引证文献14

二级引证文献71

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部